影响细胞周期基因的新型结构变异在转移性胃肠道 stromal 瘤中得到阐明
Jesús Delgado-de la Mora1, Majd Al Assaad1, Stephanie Quitian2
1Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, 1300 York Ave, New York, NY 10065, USA; Englander Institute for Precision Medicine, Weill Cornell Medicine, 413 East 69th Street, New York, NY 10021, USA.
Pathology, research and practice
|December 21, 2024
概括
晚期的胃肠道 stromal 瘤 (GISTs) 通常会抵抗治疗. 全基因组测序揭示了细胞周期基因变异,如CDKN2A/B,以及抗性GIST中的新CDK12变异,提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 基因组学就是基因组学.
背景情况:
- 胃肠道 stromal 瘤 (GIST) 是消化道中最常见的介质细胞瘤.
- 先进的GIST经常对氨酸激酶抑制剂 (TKI) 产生耐药性,这构成了重大的治疗挑战.
研究的目的:
- 通过使用全基因组测序 (WGS) 来研究对TKI耐火的转移性GIST中的遗传变化.
- 识别潜在的新治疗点,了解细胞周期基因在GIST进展中的作用.
主要方法:
- 全基因组测序 (WGS) 在三个对TKI耐药的转移性GIST样本上进行.
- 整合了499个GIST的公共队列的分析,以确定常见的遗传改变.
主要成果:
- 在转移性GIST中观察到细胞周期基因的频繁变化,包括循环林依赖激酶2A (CDKN2A) 和循环林依赖激酶2B (CDKN2B).
- 在循环林依赖激酶12 (CDK12) 中发现了新的结构变异.
结论:
- 转移性GIST的全基因组分析为瘤进展和TKI耐药性提供了关键的见解.
- 像CDK12这样的新兴点为高级GIST患者提供了新的治疗可能性,推进了精确瘤学.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


